SVR Drugs Private Limited

SVR Drugs Private Limited - pharma in Visakhapatnam, Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U24232AP2010PTC070173 Incorporated 26 August 2010 ROC Vijayawada HQ Visakhapatnam, Andhra Pradesh, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2025
₹130.85 Cr
▲ 9% YoY
Net profit · FY 2025
₹2.72 Cr
Net margin 2.1%
EBITDA · FY 2025
₹9.84 Cr
EBITDA margin 7.5%
Authorised capital
₹7 Cr
Registered with MCA
Paid-up capital
₹5.61 Cr
Issued & subscribed
Open charges
₹26.89 Cr
Satisfied ₹2 Cr
Company age
16 yrs
Est. 2010
Employees · EPFO
215
Provident fund records

About SVR Drugs Private Limited

Data last updated:

SVR Drugs Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 26 August 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24232AP2010PTC070173. Its GSTIN is 37AAOCS6986L1Z7 (Andhra Pradesh).

The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹5.61 Cr. It is led by directors including Nageswara Rao Pinneti (Managing Director) and Nagadurga Pinneti (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No:3 Jn Pharma City Tadi Cillage Parawada Mandal, Visakhapatnam, Andhra Pradesh, India – 531019.

As per the financials filed for FY 2025, the company reported a revenue of ₹130.85 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹2.72 Cr (net margin 2.1%) and EBITDA of ₹9.84 Cr (EBITDA margin 7.5%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 4% over five years.

The company has about 215 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹26.89 Cr and satisfied charges of ₹2 Cr on record. Court records list 6 cases involving the company, including 5 filed by the company and 1 filed against it. The company has 10 deals on record (6 secondary share transfers, 4 funding rounds), with disclosed funding of ₹11.4 Cr; the latest was in April 2023.

SVR Drugs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0011315). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website svrdrugs-labs.com.

Company details

CIN U24232AP2010PTC070173
Registration Number 070173
Incorporation Date 26 August 2010
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-AP-10-0011315

CIN history

SVR Drugs has one previous CIN (Corporate Identification Number): U24232TG2010PTC070173. The current CIN is U24232AP2010PTC070173, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232AP2010PTC070173Current
U24232TG2010PTC070173Previous
Key People
Nageswara Rao Pinneti Managing Director Nagadurga Pinneti Whole-Time Director Srivani Kavuturu Director

Recognitions & Rankings of SVR Drugs

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-AP-10-0011315

Contact details

SVR Drugs Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its website is svrdrugs-labs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    svrdrugs-labs.com
  • Registered Address
    Plot No:3 Jn Pharma City Tadi Cillage Parawada Mandal, Visakhapatnam, Andhra Pradesh, India – 531019
  • Industry
    Pharma, API Manufacturers

To see the full contact details of SVR Drugs Private Limited, buy the company report.

Comprehensive company report
SVR Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of SVR Drugs is manufacturing. In detail, this covers manufacture of chemicals and chemical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing20Manufacture of chemicals and chemical products

To see the full business activity and turnover split of SVR Drugs Private Limited, buy the company report.

Financials of SVR Drugs Private Limited

FY 2025 filings available

SVR Drugs Private Limited reported revenue of ₹130.85 Cr (up 9% YoY) for FY 2025.

Revenue · FY 2025
₹130.85 Cr ▲ 9%
Net profit · FY 2025
₹2.72 Cr margin 2.1%
EBITDA · FY 2025
₹9.84 Cr margin 7.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 8%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 4%
5 years · compounded
▼ 2%

Revenue rose 9% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹9.84 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.72 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin7.5%
Net Profit Margin2.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of SVR Drugs Private Limited, buy the company report.

Board of directors of SVR Drugs Private Limited

SVR Drugs has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nageswara Rao Pinneti
Also directs: S.V.R. Laboratories Private Limited, Srinag Pharma Private Limited
Managing Director29 Nov 201015 Years 11 MonthsCurrent
Srivani Kavuturu
Also directs: S.V.R. Laboratories Private Limited
Director16 Aug 20179 Years 2 MonthsCurrent
Srinivasulu Chowdary Kavuturu
Also directs: Vitex Laboratories Private Limited, S.V.R. Laboratories Private Limited, Azakem Labs Private Limited and 1 more
Director25 Apr 201214 Years 6 MonthsCurrent
Nagadurga Pinneti
Also directs: S.V.R. Laboratories Private Limited
Whole-Time Director25 Apr 201214 Years 6 MonthsCurrent
View all directors

Auditor

SVR Drugs Private Limited is audited by A.Madhusudhana & Co for the financial year 2023.

Auditor firmFinancial yearFirm registration number
A.Madhusudhana & CoFY 2023007405S

Shareholding

The shareholding of SVR Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of SVR Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹26.89 Cr
Satisfied charges
₹2 Cr
Breakdown by lending institutions
Others₹24.89 Cr
Union Bank of India₹2.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
13 Feb 201510551442Union Bank of India₹2 CrOpen
09 Mar 201210347974Others₹24.89 CrOpen
08 Nov 201410530379Union Bank of India₹2 CrSatisfied

To see the full charge records of SVR Drugs Private Limited, buy the company report.

Total charge records: 3 View all charges

Deals & funding

SVR Drugs Private Limited has 10 deals on record (6 secondary share transfers, 4 funding rounds), with disclosed funding of ₹11.4 Cr; the latest was in April 2023.

Total deals
10
Secondary share transfers
6
Funding rounds
4
Disclosed funding
₹11.4 Cr

Deals on record (5 of 10)

WhenDealAmountParties
Apr 2023Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Mar 2019Secondary share transferUndisclosedBuyer: 4 individuals
Seller: S.V.R. Laboratories Private Limited , Makeshworth Projects & Devalopers Private Limited, 2 individuals
Jan 2013Secondary share transferUndisclosedBuyer: 2 individuals
Seller: SVG Techno Industries Private Limited , 3 individuals
Mar 2012Funding round₹6.31 CrInvestors: S.V.R. Laboratories Private Limited , SSP Acisiory Services Private Limited, SVG Techno Industries Private Limited , an individual
Mar 2011Secondary share transferUndisclosedBuyer: Sv's Remedies Limited
Seller: 2 individuals

To see the full deal history of SVR Drugs Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

SVR Drugs Private Limited was last rated by Icra on 08 Oct 2021.

Rating agencyRated onRating
Icra08 Oct 2021

To see the full credit ratings and regulatory alerts of SVR Drugs Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for SVR Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

SVR Drugs Private Limited has a workforce of 215 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
215
Active EPFO establishments
1
Employee growth
10.3%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27215
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of SVR Drugs Private Limited, buy the company report.

GST

SVR Drugs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
37AAOCS6986L1Z7Andhra PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of SVR Drugs Private Limited, buy the company report.

Recent activity

SVR Drugs Private Limited has 11 board changes on record since 2010: 4 appointments and 7 cessations. The latest: Srinivasulu Chowdary Kavuturu ceased to be Whole-Time Director on 23 Dec 2020.

AGM
Svr Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Svr Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Charges
A charge with Others of Rs. 24.89 Cr registered on 09 Mar 2012 with Charge ID 10347974 was modified on 13 Mar 2025.
Ceased
Srinivasulu Chowdary Kavuturu ceased to be Whole-Time Director.
Ceased
Srivani Kavuturu ceased to be Additional Director.
Appointed
Srivani Kavuturu was appointed as Director.
Charges
A charge with Union Bank Of India amounted to Rs. 2.00 Cr with Charge ID 10551442 was registered on 13 Feb 2015.
Charges
A charge registered on 08 Nov 2014 via Charge ID 10530379 with Union Bank Of India was fully satisfied on 07 Feb 2015.
Charges
A charge with Union Bank Of India amounted to Rs. 2.00 Cr with Charge ID 10530379 was registered on 08 Nov 2014.
Ceased
Nagadurga Pinneti ceased to be Additional Director.
Ceased
Venkata Ravi Kumar Vasireddy ceased to be Additional Director.
Appointed
Nagadurga Pinneti was appointed as Whole-Time Director.

7 earlier events are in the company report.

Frequently asked questions

SVR Drugs is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 26 August 2010 (16+ years old) and is registered under CIN U24232AP2010PTC070173.

SVR Drugs has 4 current directors:

The latest financial statements of SVR Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of SVR Drugs is 37AAOCS6986L1Z7, registered in Andhra Pradesh.

The CIN (Corporate Identification Number) of SVR Drugs is U24232AP2010PTC070173. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

SVR Drugs has 6 court cases on record: 5 filed by the company and 1 filed against it.

SVR Drugs was incorporated on 26 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Vijayawada.

SVR Drugs has 10 deals on record (6 secondary share transfers, 4 funding rounds), with disclosed funding of ₹11.4 Cr; the latest was in April 2023.

Srinivasulu Chowdary Kavuturu ceased to be Whole-Time Director on 23 Dec 2020. Srivani Kavuturu ceased to be Additional Director on 28 Sep 2017. Srivani Kavuturu was appointed as Director on 16 Aug 2017. SVR Drugs has 11 board changes on record in total.

Yes, SVR Drugs is registered as a medium enterprise under Udyam registration (number: UDYAM-AP-10-0011315).